AAM SUPPORTING PETITIONERS ON SEVERABILITY | Association for Accessible Medicines
New Blog - Jonathan Kimball gives more detail re: AAM's blueprint & proposed policy framework
AAM Amicus Brief

AAM SUPPORTING PETITIONERS ON SEVERABILITY

On May 14, 2020 The Association for Accessible Medicines (AAM) filed an amicus brief in the latest constitutional challenge to the Affordable Care Act (ACA), arguing for the survival of biosimilars pathway (BPCIA), even if the individual mandate of the ACA is found unconstitutional.

View Brief

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.